SCHEMBL24302650

SCHEMBL24302650

CC(C)c1cc(OCC2CCOCC2)ccc1F

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 2/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ ACACB O00763 1/20 0.42
▸ BACE1 P56817 1/20 0.41
▸ BACE2 Q9Y5Z0 1/20 0.41
▸ PARP10 Q53GL7 2/20 0.40
▸ PARP15 Q460N3 1/20 0.40
▸ SLC6A2 P23975 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ P2RX3 P56373 1/20 0.37
▸ P2RX2 Q9UBL9 1/20 0.37
▸ SLC2A1 P11166 1/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.37
▸ SCN9A Q15858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20374442 0.90 PARP10 (0.45) ACACBPARP10PARP15SLC6A2SLC6A4
SCHEMBL24302656 0.86 SCN1A (0.46) PARP10PARP15SLC6A2SLC6A4HTR3A
SCHEMBL31632683 0.79 PARP10 (0.43) RORCCYP2D6ACACBBACE1BACE2
SCHEMBL20207072 0.79 PARP10 (0.48) BACE1BACE2PARP10PARP15FFAR4
SCHEMBL21736840 0.79 PARP10 (0.48) ACACBPARP10PARP15SLC6A2SLC6A4
SCHEMBL18374246 0.77 ACACB (0.43) ACACBPARP10PARP15FFAR4SCN9A
SCHEMBL17658890 0.74 NQO1 (0.48) MEN1KMT2AFFAR4
SCHEMBL26343438 0.74 ACACB (0.45) ACACB
SCHEMBL26343430 0.74 ACACB (0.45) ACACB
SCHEMBL26343440 0.74 ACACB (0.45) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022079432-A1 2-OXO-DIHYDROQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS GABA TYPE A RECEPTOR MODULATORS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2022-04-21 — — WO disclosed
Send feedback